Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
About this item
Full title
Author / Creator
Kantarjian, Hagop , Stein, Anthony , Gökbuget, Nicola , Fielding, Adele K , Schuh, Andre C , Ribera, Josep-Maria , Wei, Andrew , Dombret, Hervé , Foà, Robin , Bassan, Renato , Arslan, Önder , Sanz, Miguel A , Bergeron, Julie , Demirkan, Fatih , Lech-Maranda, Ewa , Rambaldi, Alessandro , Thomas, Xavier , Horst, Heinz-August , Brüggemann, Monika , Klapper, Wolfram , Wood, Brent L , Fleishman, Alex , Nagorsen, Dirk , Holland, Christopher , Zimmerman, Zachary and Topp, Max S
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Among adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, treatment with the bispecific anti-CD19 and anti-CD3 monoclonal antibody blinatumomab resulted in longer overall survival and higher remission rates than did chemotherapy.
The prognosis for adults with newly diagnosed acute lymphoblastic leukemia (ALL) has im...
Alternative Titles
Full title
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Authors, Artists and Contributors
Author / Creator
Stein, Anthony
Gökbuget, Nicola
Fielding, Adele K
Schuh, Andre C
Ribera, Josep-Maria
Wei, Andrew
Dombret, Hervé
Foà, Robin
Bassan, Renato
Arslan, Önder
Sanz, Miguel A
Bergeron, Julie
Demirkan, Fatih
Lech-Maranda, Ewa
Rambaldi, Alessandro
Thomas, Xavier
Horst, Heinz-August
Brüggemann, Monika
Klapper, Wolfram
Wood, Brent L
Fleishman, Alex
Nagorsen, Dirk
Holland, Christopher
Zimmerman, Zachary
Topp, Max S
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5881572
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5881572
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1609783
